Hialy Gutierrez, MPH,1,2 Ashwini Shewade, MS, MSc,1 Minghan Dai, MPH,1 Pedro Mendoza-Arana, MD, MSc,3 Octavio Go´mez-Dante´s, MD, MPH,4 Nishant Jain, PhD,5 Irma Khonelidze, MPA,6 Juliet Nabyonga-Orem, MD, MSc,7 Karima Saleh, PhD,8 Yot Teerawattananon, MD, PhD,9 Sania Nishtar, SI, PhD,10 and John Hor

Rapeepong Suphanchaimat1,2 Angkana Sommanustweechai1 , Chiraporn Khitdee1 , Chompoonut Thaichinda1 , Kanang Kantamaturapoj3 , Pattara Leelahavarong4 , Pensom Jumriangrit1 , Thitikorn Topothai1 , Thunthita Wisaijohn1 Weerasak Putthasri1 1International Health Policy Program (IHPP), Ministry of Publi

In response to a lack of cost-effective data on screening and early treatment of diabetes and hypertension in resource-limited settings, a model-based economic evaluation was performed on the World Health Organization (WHO)’s Package of Essential Non-communicable (PEN) disease interventions for prim

Abstract Background: Over the last decade, the prevalence of obesity (BMI ≥ 25 kg/m2) in Thailand has been rising rapidly and consistently. Estimating the cost of obesity to society is an essential step in setting priorities for research and resource use and helping improve public awareness of th

Background: In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection. Objective: This study aims to evaluate the cost-utility of all chemotherapy regimens currently used in Thailand compared with the adjuvant 5-fluorouracil

Abstract Introduction: As part of the development of a system for the screening of refractive error in Thai children, this study describes the accuracy and feasibility of establishing a program conducted by teachers. Objective: To assess the accuracy and feasibility of screening by teachers.

Abstract Background: Only lamivudine has been included for patients with chronic hepatitis B (CHB) in the National List of Essential Drugs (NLED), a pharmaceutical reimbursement list in Thailand. There have also been no economic evaluation studies of CHB drug treatments conducted in Thailand yet. I

Summary Medicines expenditure consumes a significant proportion of public health expenditure in Thailand, where Universal Health Coverage has been in place since 2002. The National List of Essential Medicines has been successfully used as a pharmaceutical benefits package for all public health plan

Juntana Pattanaphesaj and Montarat Thavorncharoensap Abstract Background: The EQ-5D is a health-related quality of life instrument which provides a simple descriptive health profile and a single index value for health status. The latest version, the EQ-5D-5L, has been translated into morethan

Yot Teerawattananon,1 Sripen Tantivess,1 Pitsaphun Werayingyong,1 Pritaporn Kingkaew,1 Nilar Tin,2 San San Aye,3 Phone Myint3 Abstract Introduction: In 2010, with financial support from the Global Alliance for Vaccine and Immunization’s Health System Strengthening programme, the Government of